Heron Therapeutics, Inc. (LON:0J4V)
1.140
-0.060 (-4.97%)
Feb 12, 2026, 3:01 PM GMT
Heron Therapeutics Market Cap
Heron Therapeutics has a market cap or net worth of 154.8 million as of February 12, 2026. Its market cap has decreased by -29.68% in one year.
Market Cap
154.80M
Enterprise Value
222.94M
Revenue
115.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.14
Market Cap Chart
Since August 26, 1987, Heron Therapeutics's market cap has increased from 36.91M to 154.80M, an increase of 319.43%. That is a compound annual growth rate of 3.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 157.24M | -11.22% |
| Dec 31, 2025 | 177.11M | -4.72% |
| Dec 31, 2024 | 185.88M | -7.20% |
| Dec 29, 2023 | 200.29M | -18.80% |
| Dec 30, 2022 | 246.68M | -64.11% |
| Dec 31, 2021 | 687.32M | -51.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Tristel | 204.62M |
| Animalcare Group | 194.02M |
| Faron Pharmaceuticals Oy | 191.04M |
| Optima Health | 189.54M |